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Hypertension is associated with cerebrovascular remodel-ing,1 a reduction in resting cerebral blood flow (CBF), 
and higher cerebrovascular resistance relative to healthy nor-
motensive individuals.2–4 Impairment in the ability to regu-
late CBF carries increased risk of cerebrovascular events and 
dementia.5–7
In a large-scale longitudinal study in 575 patients with 
manifest arterial disease, Muller et al3 found the largest re-
duction in CBF between the baseline visit and 4-year fol-
low-up in hypertensive patients who had a reduction in 
blood pressure (BP) and in patients whose BP remained 
high at the 4 years of follow-up. A reduction in CBF has 
also been observed with antihypertensive treatment,8 and 
lower CBF has been measured in treated controlled versus 
untreated hypertensive patients.4 However, the effect of 
antihypertensive medication on CBF control is poorly 
understood.9
In response to a BP challenge such as lower body nega-
tive pressure (LBNP), which simulates hypovolemia (online-
only Data Supplement), several studies report reduced CBF 
velocity (a surrogate measure of blood flow) in the middle 
cerebral artery, assessed by transcranial Doppler ultrasonog-
raphy (TCD) in healthy volunteers.10–13 Studies examining the 
dynamic regulation of CBF in hypertension in response to 
changes in BP show mixed results, with some showing pre-
served ability to regulate flow compared with normotensive 
individuals14,15 and others showing an impairment of regula-
tion.16,17 Given that hypertension is associated with structural 
changes in response to increased transmural pressure, such as 
arterial stiffening and atherosclerosis,18–20 it remains unclear 
whether the arterial remodeling may contribute to the altered 
CBF regulation. Any impairment in the regulation of CBF and 
lower perfusion at rest may risk oxygen deprivation and is-
chemia in hypertensive patients.
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Abstract—Hypertension is associated with raised cerebral vascular resistance and cerebrovascular remodeling. It is currently 
unclear whether the cerebral circulation can maintain cerebral blood flow (CBF) during reductions in cardiac output (CO) 
in hypertensive patients thereby avoiding hypoperfusion of the brain. We hypothesized that hypertension would impair the 
ability to effectively regulate CBF during simulated hypovolemia. In the present study, 39 participants (13 normotensive, 
13 controlled, and 13 uncontrolled hypertensives; mean age±SD, 55±10 years) underwent lower body negative pressure 
(LBNP) at −20, −40, and −50 mmHg to decrease central blood volume. Phase-contrast MR angiography was used to 
measure flow in the basilar and internal carotid arteries, as well as the ascending aorta. CBF and CO decreased during LBNP 
(P<0.0001). Heart rate increased during LBNP, reaching significance at −50 mmHg (P<0.0001). There was no change in 
mean arterial pressure during LBNP (P=0.3). All participants showed similar reductions in CBF (P=0.3, between groups) 
and CO (P=0.7, between groups) during LBNP. There was no difference in resting CBF between the groups (P=0.36). In 
summary, during reductions in CO induced by hypovolemic stress, mean arterial pressure is maintained but CBF declines 
indicating that CBF is dependent on CO in middle-aged normotensive and hypertensive volunteers. Hypertension is not 
associated with impairments in the CBF response to reduced CO.  (Hypertension. 2019;74:1391-1398. DOI: 10.1161/
HYPERTENSIONAHA.119.13229.) • Online Data Supplement
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In healthy volunteers, regulation of CBF is crucially de-
pendent on alterations in cardiac output (CO).21,22 However, 
whether CO plays a role in maintaining CBF in patients with 
hypertension is unknown. Thus, the main aim of this study 
was to assess whether the CBF response to reductions in CO 
is impaired in people with hypertension compared with an 
age-matched normotensive cohort. We recruited 2 groups of 
hypertensive patients, those with either treated controlled 
(controlled hypertensives) or uncontrolled BP (uncontrolled 
hypertensives), to assess whether these groups respond dif-
ferently to reductions in CO. We hypothesized that patients 
with hypertension would have a larger reduction in CBF in 
response to a decrease in CO induced by LBNP. We also 
hypothesized that because uHTNs are likely to have more 
adverse arterial remodeling versus cHTN,8,19,20,23 this group 
would have a larger decline in CBF during a reduction in CO.
Methods
This study was approved by the UK National Research Ethics 
Committee (reference: 15/SW/0176) and the Institutional Research 
and Innovation Department at the University Hospitals Bristol NHS 
Foundation Trust. All methods conformed to the Declaration of 
Helsinki, as well as local and UK national guidelines. Data and anal-
ysis is available on request from https://data.bris.ac.uk/data/.
Participants and Screening
A total of 39 eligible men and women were recruited for the study, 
of which 13 were normotensive, 13 were hypertensive with BP con-
trolled by medication (cHTN), and 13 were uncontrolled hyperten-
sives (uHTN; Table). Participants were age matched and grouped 
based on daytime ambulatory BP averaged over at least 14 measure-
ments, in accordance with 2018 European Guidelines for diagnosis of 
hypertension. The normotensive and cHTN groups were defined as a 
daytime ambulatory BP of <135/85 mmHg. uHTN was defined as a 
daytime ambulatory BP of >135/85 mmHg, either without or despite 
being prescribed antihypertensive medication. The uHTN group was 
included to investigate the effect of raised resting BP.
All participants gave written informed consent. Participant 
screening procedures and eligibility is detailed in the online-only 
Data Supplement.
Lower Body Negative Pressure
A magnetic resonance (MR) imaging compatible polycarbonate box 
was fitted to encompass the lower torso and legs (online-only Data 
Supplement). A broad polyurethane skirt was wrapped around the 
waist and secured over the box providing an airtight seal. The par-
ticipants were positioned with their feet flat against the end of the 
box to prevent the participant being pulled further into the box by the 
suction. A commercially available vacuum cleaner with continuous 
variable power (Sebo Airbelt K1 1800 W) was attached to the box. 
The negative pressure achieved inside the box was monitored with 
an MR safe pressure gauge (SM Gauge) continuously indicating the 
pressure within the box (relative to atmospheric).
The LBNP protocol was graded at −20, −40, and −50 mmHg 
in descending order. Participants were maintained at each level of 
LBNP for 1 minute before imaging. Each phase-contrast scan took 
≈5.5 minutes.
Physiological Monitoring
An automated sphygmomanometer measured BP and heart rate (HR) 
every 1.5 to 2 minutes during each phase-contrast acquisition. An av-
erage of the measurements was taken for each level of LBNP. A nasal 
cannula was connected to a calibrated capnograph (Capstar100; 
CWE, Inc) to measure the percentage of expired end-tidal CO2. 
Breathing rate was not monitored in the study. However, a sus-
pected change to mouth breathing was considered when little-to-no 
end-tidal CO2 was detected; this was seen as a near-flat line of the 
end-tidal CO2 trace.
MR Imaging
All MR images were acquired during free breathing at 1.5T (Siemens 
Avanto Magnetom, Siemens Healthineers).
Phase-Contrast MR Angiography
ECG-gated phase-contrast MR angiography was used to measure (1) 
CBF in the basilar and internal carotid arteries, in the transverse plane 
perpendicular to the internal carotid arteries at the level of the basilar 
artery, followed by (2) flow in the ascending aorta in the transverse 
plane, at the level of the main pulmonary trunk (i.e., CO). All flow 
imaging was performed at isocenter. Examples of flow data in the in-
tracranial arteries and the aorta are shown in Figure S1 in the online-
only Data Supplement.
Time-of-Flight Angiogram
The time-of-flight angiogram was covering the superior vertebral 
arteries and the entirety of the Circle of Willis. Time-of-flight images 
were used primarily to position the phase-contrast images for the 
intracerebral flow measurements. However, a 3-slice localizer with 
slice thickness of 5 mm was used for the repositioning of the flow 
slices during LBNP to ensure a consistent positioning regardless of 
movement of the subject due to suction. An example angiogram is 
shown in Figure S1.
T1-MPRAGE
A 3-dimensional T1-weighted scan (T1-MPRAGE) was acquired in 
the transverse plane.
Statistical Analysis
MR image analysis is outlined in the online-only Data Supplement.
We calculated that a sample size of 11 in each group provides a 
power of 80% to find a 17% difference (estimated based on24 Abstract) 
in resting CBF between the uHTN and normotensive groups with a 
2-sided α of 0.05.
Inter- and intraobserver variability data are available in the on-
line-only Data Supplement.
Mean arterial BP (MAP) was calculated as MAP=diastolic BP 
(DBP)+ 1
3
 (pulse pressure). Total peripheral resistance (TPR) was es-
timated as TPR MAP mm Hg
CO L min
=
( )
( / )
Cerebrovascular conductance was calculated as: 
Cerebrovascular conductance total cerebral blood flow mL= ( / )( )
min
mean arterial pressure mm Hg
Analyses were completed in Prism v7 (GraphPad Software) un-
less otherwise stated.
Normality of distribution in the data was assessed by D’Agostino-
Pearson. CO did not pass the test of normality and was transformed 
by a log10 transformation.
Mean differences between the groups during LBNP were ana-
lyzed using mixed-model ANOVA and compared using Tukey mul-
tiple comparisons with respect to resting values. Mean differences 
between the groups at rest were analyzed by a 1-way ANOVA and 
Bonferroni correction for multiple comparison. Analysis by sex is 
presented in the online-only Data Supplement.
A 3-way ANOVA with factors artery, LBNP, and group was 
performed to assess potential interactions between the arteries and 
groups during LBNP (SPSS v23; IBM).
Vascular remodeling and structural incidents related to vascular 
disease are included in the online-only Data Supplement. The data are 
reported as mean and SD. α was set at 0.05.
Results
All participants completed the experimental protocol. One 
participant who, due to presyncopal symptoms, was unable to 
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tolerate LBNP of −50 mmHg, had incomplete data for aortic 
flow and was excluded from all assessments of CO. In 9 par-
ticipants, end-tidal CO2 was not reliably recorded because of 
technical difficulties.9 These participants were removed from 
the CO2 analysis. Incidence of stenosis can be found in Table 
S1 presented in the online-only Data Supplement. Only mild 
stenosis was observed. Interestingly, 4 of the normotensives 
showed stenosis versus 3 in uHTN and 0 in cHTN.
Participants
The participant demographics are summarized in the Table. 
There were no differences in the average age, body mass index, 
or sex ratio between groups. Clinic and ambulatory BPs were 
higher in the uHTN compared with normotensive and cHTN 
(1-way ANOVA; clinic systolic blood pressure [SBP], P=0.0076; 
ambulatory SBP, P<0.0001; ambulatory DBP, P=0.0019) but 
not clinic DBP (P=0.05). There was no difference in BP be-
tween normotensive and cHTN (clinic SBP, P>0.99; clinic DBP, 
P>0.99; ambulatory SBP, P=0.15; ambulatory DBP, P>0.99).
Physiological Responses
Figure 1 shows BP, HR, TPR, and CO responses to LBNP. 
There was an increase in HR at a LBNP of −50 mmHg only 
(5.4% of the total variance, P<0.0001) with no difference be-
tween the groups (1.7% of the total variation, P=0.7). There 
was no change in MAP with LBNP (0.16% of the total varia-
tion, P=0.3), nor an interaction of the change in MAP between 
groups and LBNP (0.49% of the total variation, P=0.09). 
Overall, SBP was significantly lowered by LBNP (1.48% 
of the total variation, P=0.0013), at −50 mmHg LBNP only 
when compared with rest (P=0.013). There was no interaction 
effect between LBNP and group on SBP (0.3% of the total 
variation, P=0.7). DBP increased with LBNP (0.7% of the 
total variation, P=0.0058), at −40 mmHg (P=0.01) and −50 
mmHg (P=0.01). DBP was significantly different between 
groups (16.75% of the total variation, P=0.03), and there was 
an interaction of DBP between LBNP and group (0.98% of 
the total variation, P=0.0054). DBP significantly increased in 
the normotensive group at −50 mmHg (P=0.0024) and in the 
Table. Demographics
Variable NTN cHTN uHTN P Value
Age, years 52.9±8.9 55.0±11.1 57.6±9.7 0.49
BMI, kg/m2 26.4±2.0 27.9±2.4 27.4±3.5 0.36
Male:female ratio 7:6 5:8 7:6 NA
Pre:postmenopausal women 4:2 5:3 2:4 NA
Clinic SBP, mmHg 132.9±15.3 132.6±17.3 152.2±15.1* 0.0076
Clinic DBP, mmHg 82.6±8.7 82.5±7.0 90.0±6.4 0.053
Daytime SBP, mmHg 121.8±7.3 127.6±8.5 142.5±5.6† <0.0001
Daytime DBP, mmHg 79.0±6.7 79.7±5.9 88.4±7.9‡ 0.0019
Daytime HR, bpm 76±72.8 75.0±9.8 67.6±8.3 0.16
nCBF, mL/100 g per min 47±10.7 43±4.9 44±8.8 0.36
CBF velocity, cm/s 27±7.8 25±4.5 24±5.1 0.48
CO, L/min 4.8±0.8 5.1±0.9 4.7±1.3 0.64
Medications NA
  ACE inhibitor 0 6 5  
  ARB 0 2 1  
  α1 blocker 0 0 1  
  β-Blocker 0 0 1  
  Ca2+Ch blocker 0 5 3  
  Diuretics 0 2 2  
  No antihypertensive 13 0 5 NA
  >1 antihypertensive 0 1 1  
  >2 antihypertensives 0 3 2  
The main difference was seen in the BP readings between the hypertensive and normotensive volunteers. No other measure was 
significantly different. All data represent mean±SD. α1 blocker indicates α1-adrenergic receptor antagonist; ACE, angiotensin-
converting enzyme; ARB, angiotensin receptor II blocker; BMI, body mass index; BP, blood pressure; Ca2+Ch blocker, Ca2+ channel 
inhibitor; CBF, cerebral blood flow; cHTN, controlled hypertensives; CO, cardiac output; DBP, diastolic blood pressure; HR, heart rate; 
NA, not available; nCBF, normalized cerebral blood flow; NTN, normotensive; SBP, systolic blood pressure; and uHTN, uncontrolled 
hypertensives.
*P<0.5.
†P<0.01.
‡P<0.001.
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cHTN group (P=0.034) but not the uHTN (P=0.9). Between-
group Dunnett post hoc comparisons showed a significant dif-
ference for DBP between the normotensive and uHTN only 
(P=0.01).
LBNP increased TPR (11.25% of the total variation, 
P<0.0001). There was no interaction between the change in 
TPR during LBNP and group (0.14% of the total variation, 
P=0.90). There was a reduction in end-tidal CO2 with LBNP 
(5.4% of the variation, P<0.0001; n=30). Compared with 
rest, the reduction was 0.08% at −20 mmHg (P=0.3), 0.2% at 
−40 mmHg (P=0.0009) and 0.3% at -50 mmHg (P<0.0001). 
Regarding end-tidal CO2, there was no difference between 
groups (1.0% of the variation, P=0.8) or interaction between 
LBNP and group (0.16% of the variation, P=0.9). However, a 
change from nasal to oral breathing was observed at −50 mmHg 
LBNP. Unfortunately, we did not measure breathing rate, and 
as such, no data are available on the minute ventilation.
Cardiac Output
There was a reduction in CO during LBNP (17.99% of the 
variation, P<0.0001), with no difference between the groups 
(1.28% of the total variation, P=0.74) or interaction between 
LBNP and group (0.28% of the total variation, P=0.53). CO 
was reduced compared with rest at −20 (P<0.0001), −40 
(P<0.0001), and −50 mmHg (P<0.0001) in all participants 
(Figure 1).
Cerebral Blood Flow
Figure 2 shows total CBF (tCBF), normalized CBF, and ce-
rebrovascular conductance during LBNP. Resting normalized 
CBF was similar between the groups (Table). Normalized 
CBF (8.2% of the variation, P<0.0001) and blood flow ve-
locity (2% of the total variation, P<0.0001) were reduced by 
LBNP. Post hoc tests revealed a significant reduction in nor-
malized CBF at −40 (P<0.0001) and −50 mmHg (P<0.0001) 
but not at −20 mmHg (P=0.13). There was no interaction be-
tween LBNP and group (0.4% of the variation, P=0.78).
LBNP reduced CBF in all 3 intracranial arteries measured 
(basilar and internal carotid arteries, P<0.0001) with no inter-
action between LBNP and artery (P=0.64) or between LBNP, 
artery, and group (P=0.92; Figure S3).
There was a reduction in cerebrovascular conductance 
during LBNP (4.9% of the total variation, P<0.0001), with 
no difference between the groups (11.35% of the total varia-
tion, P=0.07) or interaction between LBNP and group (0.5% 
of the total variation, P=0.47). Cerebrovascular conductance 
was reduced at −40 (P=0.0004) and −50 mmHg (P<0.0001) 
but not at −20 mmHg (P=0.053). No correlation was observed 
between the change in end-tidal CO2 and the change in tCBF 
(r=0.07, P=0.7116).
On average, tCBF reduced by −3.9% at −20 mmHg, −8.2% 
at −40 mmHg, and by −14.6% at −50 mmHg LBNP from rest-
ing values. There was an increase (3.2% of the total variation, 
Figure 1. Physiological responses to lower 
body negative pressure (LBNP). A, Mean 
arterial blood pressure (MAP; mmHg) was 
unchanged during LBNP but higher in the 
uncontrolled hypertensives (uHTN). B, Heart 
rate (beats per minute) increased during LBNP 
at −50 mmHg with no difference between the 
groups. C, Systolic blood pressure (mmHg) 
showed a significant reduction at −50 mmHg, 
as well as a consistently higher pressure in the 
uHTN compared with normotensives (NTN). 
D, Diastolic blood pressure (mmHg) was 
significantly increased at −40 and −50 mmHg 
LBNP, as well as being higher in the uHTN 
group. E, cardiac output (L/min) decreased 
during LBNP with no difference between the 
groups. F, Total peripheral resistance (mmHg/L 
per min) increased with LBNP in all groups and 
was persistently higher in the uHTN, P above 
the line refers to ANOVA main effect of LBNP. 
* & $ P<0.05, ** & $$ P<0.01, *** & $$$ P<0.001 
are multiple comparison P where * is NTN 
vs uHTN and $ LBNP vs rest. ns indicates 
nonsignificant.
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P=0.0027; n=38) in the percentage of the CO that was distrib-
uted to the brain (i.e., percentage of CO measured as tCBF at 
any given level of LBNP). This difference amounted to 0.75% 
at −20 mmHg (P=0.12), 1.35% at −40 mmHg (P=0.0015), 
and 1.15% at −50 mmHg (P=0.0081). There was no differ-
ence between the groups (7.1% of the total variation, P=0.17) 
and no interaction between the change in the percentage of the 
CO going to the brain during LBNP and group (0.5% of the 
total variation, P=0.86).
Discussion
The novel finding in this study was that despite an absence 
of a change in MAP, tCBF decreased with LBNP-mediated 
reductions in CO by a comparable value in normotensive, 
uHTN, and cHTN. Thus, both normotensive and hypertensive 
volunteers appear equally unable to maintain tCBF during 
simulated hypovolemia.
In the present study, the baroreflex-mediated increase in 
HR during LBNP was not sufficient to compensate for the 
reduction in CO. MAP was unchanged in all groups during 
LBNP, explained by an increase in TPR. Thus, cerebral perfu-
sion pressure appears to be maintained during simulated hypo-
volemia despite the reduction in CO. These data are consistent 
with previous studies in normotensive subjects where middle 
cerebral artery CBF velocity was reduced during LBNP with 
unchanged MAP.25,26
Methodological Considerations
Previous studies have largely relied on TCD to estimate 
changes in blood flow in cerebral vessels. TCD measures 
the mean velocity as a surrogate of flow and assumes a static 
caliber of the vessel. It is dependent on the insonation angle, 
which must be perpendicular to the center of the vessel, and 
on the cross-sectional area of the vessel, which is assumed to 
be constant. Although it has been argued that the change in 
the cross-sectional area of the artery during BP challenges and 
the pulsation during the cardiac cycle are negligible,14,27 this 
assumption may not hold true when comparing arteries in hy-
pertensive individuals to those of normotensives. By compar-
ison, MR phase-contrast angiography offers a repeatable and 
more reliable means for measuring blood flow.28,29 Leung et 
al28 proposed that phase-contrast angiography is more appro-
priate for studies wishing to quantify other derived measures 
such as cerebrovascular resistance, as we have done herein.
Additionally, MR phase-contrast imaging allows simulta-
neous measurement of blood flow in the intracranial parts of 
the internal carotid and basilar arteries, which are not easily 
accessible with TCD, and provides a measure of global CBF. 
However, TCD provides information about dynamic changes 
in blood flow velocity that cannot be provided by magnetic 
resonance imaging. While both TCD and phase-contrast an-
giography depend on the angle with respect to the vessel at 
which the measurement is taken, phase-contrast angiography 
offers a more reliable and verifiable positioning of the meas-
urement compared with TCD, for example, by the acquisition 
of linked time-of-flight angiograms, as was done in this study.
The present study was not designed to look at the effect of 
antihypertensive medication on CBF regulation. A rapid ad-
aptation of CBF in response to antihypertensive therapy has 
been reported.23 This represents a significant limitation to the 
present study. It is important to note that both the cHTN and 
uHTN groups presented with a variety of antihypertensive 
medications, dosages, and combinations of ≥2 treatments used 
in conjunction. Nonetheless, the present study assessed these 
groups to explore the effect of controlled and uncontrolled BP, 
rather than the effect of treatment on CBF. Therefore, these 
groups largely reflect the spectrum of patients typically found 
in clinics.
Cardiovascular Responses to LBNP
The decrease in CO was similar to that observed after 25 min-
utes of prolonged standing in the same position, where CO 
was reduced by 1.4 L/min.30 This is similar to the 1.1 L/min 
reduction in CO observed at −50 mmHg LBNP; indicating 
Figure 2. Cerebral blood flow (CBF) during 
lower body negative pressure (LBNP) to −50 
mmHg. A, total cerebral blood flow (tCBF) (L/
min) decreased with LBNP. B, Normalized CBF 
(nCBF) decreased with LBNP. C, Percentage 
of the cardiac output (CO) to the brain (%) 
increased with LBNP. D, Cerebrovascular 
conductance (mL/min per mmHg) decreased 
with LBNP and showed a lower conductance 
in the uncontrolled hypertensives (uHTN) 
at −40 and −50 mmHg compared with the 
normotensives (NTN). P above the line refers 
to ANOVA main effect of LBNP. * & $ P<0.05, 
** & $$ P<0.01, *** & $$$ P<0.001 are multiple 
comparison P where * is NTN vs uHTN and $ 
LBNP vs rest.
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that the change in CO in our study represents a physiolog-
ically relevant stressor to the cardiovascular system. During 
LBNP, cerebrovascular conductance decreased, suggesting 
that vasoconstriction occurred in the intracranial cerebral 
circulation. This is in contrast to the increase in cerebrovas-
cular conductance reported previously in healthy volunteers.31 
Consistent with the present results, several other studies 
have shown a decrease in cerebrovascular conductance dur-
ing LBNP in healthy volunteers.11,12,21,25,32 One limitation of 
cerebrovascular conductance estimation is that conductance 
is inferred from peripheral arterial pressure measurements. 
Measuring intraarterial pressure in the cerebral circulation is 
technically challenging and currently not possible to achieve 
noninvasively. No studies have measured the linearity or re-
lationship between brachial pressure and intracerebral BP in 
vivo. However, in the supine position, hydrostatic column 
effects are minimal, and, therefore, the head perfusion pres-
sure is likely to be similar to brachial pressure.33
We demonstrated a reduction end-tidal CO2 during LBNP 
that may have contributed to the reduced cerebral vascular 
conductance. Although a reduction in end-tidal CO2 during 
LBNP has been reported before,10,11 it is important to note that 
we measured end-tidal CO2 through a nasal cannula and did 
not monitor respiratory rate. If the participants were breathing 
through the mouth rather than nose during increased LBNP, 
this would explain the decrease in the measured end-tidal CO2. 
Alternatively, the reduction in end-tidal CO2 may be explained 
by the fall in CO. Regardless, even with CO2 clamped at rest-
ing levels, a reduction in CBF velocity has been measured 
with LBNP.34
Brain Blood Flow During LBNP
Previous reports have pointed to a lower resting CBF in 
patients with hypertension.2,4 We did not replicate this find-
ing; however, a difference in sample size or methodological 
differences could explain this discrepancy. Warnert et al4 used 
phase-contrast angiography with a greater spatial resolution 
(voxel size, 0.9×0.9×2 mm3) in >100 participants but acquired 
only 9 reconstructed phases over the cardiac cycle. Therefore, 
while Warnert et al4 had good spatial resolution and thus re-
liable measurements of vessel diameter, 9 frames per cardiac 
cycle equates to an effective temporal resolution of ≈111 ms 
(assuming a HR of 60 beats per minute), which will inescap-
ably lead to undersampling.35 By contrast, the present study 
acquired phase-contrast flow with 100 reconstructed phases 
over the cardiac cycle, equating to an effective temporal res-
olution of ≈10 ms. The 10-fold higher temporal resolution of 
the current study allows for a more detailed and reliable char-
acterization of flow throughout the cardiac cycle. Lastly, the 
current study sample comprised middle-aged subjects who 
may show less pronounced differences in resting CBF, when 
compared with an older demographic with more advanced 
vascular disease.3
Three main theories on how the body maintains optimal 
brain blood flow are relevant and should be considered. First, 
proportional blood distribution states that blood flow to each 
organ is a fixed percentage of the CO, and each organ’s share 
is based on their metabolic demand.22,36 The present study 
does not support this theory given that the percentage of the 
CO going to the brain increased (albeit by 1%) with LBNP. 
Second, based on the principles of Poiseuille law, the perfu-
sion of any organ depends on the arterial pressure and vascular 
resistance. In the present study, the lower flow and conduct-
ance observed in response to a reduced CO may have been 
compensated for by vasoconstriction of the cerebral circula-
tion (e.g., triggered by hypocapnia) thereby maintaining per-
fusion pressure. Third, as the regulation of CBF is critical for 
maintaining constant nutrient and oxygen supply to the brain, 
a brain-specific theory for the regulation of blood flow, re-
ferred to as the selfish brain hypothesis, has been proposed. 
According to this theory, the body prioritizes CBF and adjusts 
peripheral BP to adjust flow to the brain to maintain constant 
perfusion.37 The theory further proposes that hypertension is 
caused by a reduction in brain stem perfusion driving up BP 
to normalize the perfusion. Eventually, the BP becomes insuf-
ficient to compensate for the lowered perfusion, leading to a 
permanently lowered CBF.4
The current study suggests that irrespective of high BP, 
the brain is able to tolerate a reduction in tCBF when CO 
falls at rest. The fact that CBF fell by −14.6% at −50 mmHg 
LBNP supports this idea. However, this claim may be chal-
lenged by the increase seen in the percentage of the CO going 
to the brain, suggestive of a degree of priority given to brain 
perfusion. Indeed, we saw an increase of ≈1% at −50 mmHg 
LBNP. This supports the selfish brain hypothesis in that CBF 
is given priority through an increase in the proportional dis-
tribution ably assisted by increasing peripheral vascular re-
sistance to maintain arterial pressure. However, at −40 mmHg 
where CBF was reduced by an average of −8.2%, an equiva-
lent increase in the percentage of the CO going to the brain 
was observed (i.e., a mere 1%), suggesting a reserve would 
still be available at this level given the steady decline in CO, 
unchanged MAP, and HR. Furthermore, we did not measure 
blood flow to any other organ and, therefore, do not have in-
formation on whether the redistribution of blood flow may be 
unique to the brain.
Perspectives
Reductions in CBF caused by conditions that lower CO in 
populations with already low resting CBF and extensive mi-
crovascular disease may put the cerebral circulation at risk of 
hypoperfusion and ischemic events.
Given that MAP was unchanged during LBNP, this may 
suggest that, so long as perfusion pressure can be maintained, 
a reduction in CBF as a consequence of reduced preload is 
tolerated. As the brain has a limited capacity for metabolic 
substrate storage,38 the lower CBF must still be able to meet 
the metabolic demands. It is, therefore, of interest to know 
whether a cognitive task would increase CBF under condi-
tions of LBNP or whether the performance on such a task 
would suffer. Under resting conditions, it may be assumed 
that sufficient CBF was available to meet demand. This can 
be achieved either through a change in the extraction fraction 
of metabolic substrate from the blood during perfusion, for 
example, by the slowing of blood flow as seen in the present 
study, or by an abundance of blood flow at rest. Importantly, 
these mechanisms are likely to be dependent on the perfu-
sion pressure to maintain the substrate exchange across the 
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blood-brain barrier. Future studies should focus on measuring 
the perfusion of the brain with respect to oxygen extraction 
during a hypovolemic challenge to better understand whether 
lowering of CBF has functional consequences.
Conclusions
In summary, the study shows that in middle-aged men and 
women, tCBF decreases when CO decreases. Since MAP 
was maintained during LBNP, this suggests that cerebral per-
fusion pressure was unchanged despite a reduction in tCBF. 
There was no difference in the decline in CBF between nor-
motensive and hypertension groups, indicating that hyperten-
sion does not impact the regulation of CBF during simulated 
hypovolemia.
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What Is New?
•	We demonstrate that blood flow to the brain reduces when the amount of 
blood pumped by the heart is reduced by simulated blood loss. And this 
reduction in blood flow to the brain is similar in people with high blood 
pressure to those with normal blood pressure.
What Is Relevant?
•	Understanding the effect of blood pressure on brain blood flow is impor-
tant because poor regulation of brain blood flow is linked to an increased 
risk of stroke and dementia. This study suggests that cardiac output can 
change brain blood flow even without a change in blood pressure.
Summary
Simulated blood loss lowers cardiac output without lowering blood 
pressure and results in lower blood flow to the brain. Blood flow 
and blood flow regulation are similar in people with high and those 
with normal blood pressures.
Novelty and Significance
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